Cannabis Law Report

JUNE 15, 2021

In addition to eliminating criminal penalties for drug possession at the federal level, the bill also incentivizes state and local governments to adopt decriminalization policies by otherwise limiting their eligibility to receive funds in the Byrne and COPS grant programs. to Decriminalize Drug Use and Possession.

Decriminalization 78

Decriminalization Policy Research and Development Data 78

Veriheal

AUGUST 24, 2022

The city of Denver, Colorado, decriminalized the possession and use of psilocybin in 2019—the first U.S. If passed, the Department of Regulatory Agencies would be required to develop rules that would allow for therapeutic psychedelic programs at licensed healing centers for adults to receive psychedelic treatments by a trained facilitator.

Legalization 108

Legalization Medicine Decriminalization Research and Development 108

Cannabis Law Report

MAY 29, 2022

Widespread approval for psychedelic treatments remains unlikely, but the tide is slowly turning. 7] And cities around the country are beginning to decriminalize some psychedelics, with advocates for decriminalization citing the potential medical benefits. DEA and the Controlled Substances Act. Defining Psychedelics.

Research and Development 52

Research and Development DEA Clinical Trials Therapy 52

Cannabis Law Report

JULY 9, 2021

Not only are more and more jurisdictions decriminalizing the use of psychedelics for recreational purposes, but it appears that psychedelic substances are the new horizon for the treatment of severe psychological disorders and other ailments. Published Via JD Supra. The state of the law on psychedelic substances is in flux. 10; 312.80-88;

Law 105

Law Therapy Clinical Trials Research and Development 105

The Cannigma

JULY 3, 2023

Moreover, since both cannabis and MDMA are on their way to either descheduling, decriminalization or legalization around the world, this number is likely to grow. They found that it could be used in sessions to promote trust and safety, helping patients to open up and process traumatic experiences. That’s around 2.5 million people.

Research and Development 46

Research and Development Environment THC Microdosing 46

Canna Law Blog

NOVEMBER 6, 2021

To acknowledge its impressive safety record and potential for treating depression more effectively than existing therapies, the Food and Drug Administration designated psilocybin a breakthrough therapy in 2018 and 2019 for treating drug-resistant depression and major depressive disorder. That power is typically delegated to the DEA.

Clinical Trials 98

Clinical Trials DEA Research and Development Therapy 98

Canna Law Blog

MARCH 4, 2020

People are increasingly using ketamine for ailments that resist treatment through traditional pharmaceutical drugs. Recently, the decriminalization of psilocybin (by various cities) has been in the news as an emerging medicine.

Therapy 90

Therapy Legalization Chronic Pain DEA 90